Literature DB >> 11125734

Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia.

M G Giovannini1, L Bartolini, L Bacciottini, L Greco, P Blandina.   

Abstract

In previous research we found that pre-training administration of histamine H3 receptor agonists such as (R)-alpha-methylhistamine and imetit impaired rat performance in object recognition and a passive avoidance response at the same doses at which they inhibited the release of cortical acetylcholine in vivo. Conversely, in the present study we report that the post-training administration of (R)-alpha-methylhistamine and imetit failed to affect rat performance in object recognition and a passive avoidance response, suggesting that H3 receptor influences the acquisition and not the recall processes. We also investigated the effects of two H3 receptor antagonists, thioperamide and clobenpropit, in the same behavioral tasks. Pre-training administration of thioperamide and clobenpropit failed to exhibit any procognitive effects in normal animals but prevented scopolamine-induced amnesia. However, also post-training administration of thioperamide prevented scopolamine-induced amnesia. Hence, the ameliorating effects of scopolamine-induced amnesia by H3 receptor antagonism are not only mediated by relieving the inhibitory action of cortical H3 receptors, but other mechanisms are also involved. Nevertheless, H3 receptor antagonists may have implications for the treatment of degenerative disorders associated with impaired cholinergic function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11125734     DOI: 10.1016/s0166-4328(99)00063-7

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  18 in total

Review 1.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

2.  H3 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing retrieval.

Authors:  Vincent Pascoli; Corinne Boer-Saccomani; Jean-François Hermant
Journal:  Psychopharmacology (Berl)       Date:  2008-05-22       Impact factor: 4.530

Review 3.  The histamine H3 receptor: an attractive target for the treatment of cognitive disorders.

Authors:  T A Esbenshade; K E Browman; R S Bitner; M Strakhova; M D Cowart; J D Brioni
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

Review 4.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

5.  Rapamycin inhibits mTOR/p70S6K activation in CA3 region of the hippocampus of the rat and impairs long term memory.

Authors:  D Lana; J Di Russo; T Mello; G L Wenk; M G Giovannini
Journal:  Neurobiol Learn Mem       Date:  2016-11-10       Impact factor: 2.877

Review 6.  Brain histamine modulates recognition memory: possible implications in major cognitive disorders.

Authors:  Gustavo Provensi; Alessia Costa; Ivan Izquierdo; Patrizio Blandina; Maria Beatrice Passani
Journal:  Br J Pharmacol       Date:  2018-09-22       Impact factor: 8.739

7.  In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity.

Authors:  Simona Bertoni; Vigilio Ballabeni; Lisa Flammini; Francesca Saccani; Giuseppe Domenichini; Giovanni Morini; Mara Comini; Mirko Rivara; Elisabetta Barocelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-22       Impact factor: 3.000

8.  Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of freely moving rats.

Authors:  Patrizia Giannoni; Andrew D Medhurst; Maria Beatrice Passani; Maria Grazia Giovannini; Chiara Ballini; Laura Della Corte; Patrizio Blandina
Journal:  J Pharmacol Exp Ther       Date:  2009-10-08       Impact factor: 4.030

9.  The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortex.

Authors:  Natalie Welty; James R Shoblock
Journal:  Psychopharmacology (Berl)       Date:  2009-10-01       Impact factor: 4.530

10.  Single dose of H3 receptor antagonist--ciproxifan--abolishes negative effects of chronic stress on cognitive processes in rats.

Authors:  Emil Trofimiuk; Jan J Braszko
Journal:  Psychopharmacology (Berl)       Date:  2013-08-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.